- Home
- CNF vs INCR Comparison
CNF vs INCR Comparison
Compare CNF & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNF
- INCR
- Stock Information
- Founded
- CNF 1999
- INCR 1994
- Country
- CNF China
- INCR Israel
- Employees
- CNF N/A
- INCR N/A
- Industry
- CNF Finance: Consumer Services
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- CNF Finance
- INCR Health Care
- Exchange
- CNF Nasdaq
- INCR Nasdaq
- Market Cap
- CNF 89.2M
- INCR 80.1M
- IPO Year
- CNF 2018
- INCR N/A
- Fundamental
- Price
- CNF $1.04
- INCR $1.17
- Analyst Decision
- CNF
- INCR
- Analyst Count
- CNF 0
- INCR 0
- Target Price
- CNF N/A
- INCR N/A
- AVG Volume (30 Days)
- CNF 52.3K
- INCR 43.7K
- Earning Date
- CNF 11-27-2024
- INCR 11-26-2024
- Dividend Yield
- CNF N/A
- INCR N/A
- EPS Growth
- CNF N/A
- INCR N/A
- EPS
- CNF 0.24
- INCR N/A
- Revenue
- CNF $109,788,152.00
- INCR $72,420,918.00
- Revenue This Year
- CNF N/A
- INCR N/A
- Revenue Next Year
- CNF $13.09
- INCR $39.30
- P/E Ratio
- CNF $4.42
- INCR N/A
- Revenue Growth
- CNF 12.99
- INCR N/A
- 52 Week Low
- CNF $0.86
- INCR $1.06
- 52 Week High
- CNF $2.84
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- CNF 40.48
- INCR 16.78
- Support Level
- CNF $1.07
- INCR $1.70
- Resistance Level
- CNF $1.54
- INCR $1.78
- Average True Range (ATR)
- CNF 0.13
- INCR 0.08
- MACD
- CNF -0.02
- INCR -0.05
- Stochastic Oscillator
- CNF 10.71
- INCR 0.00
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.